Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitorsHidetoshi Sumimoto, Yataro Daigo, Satoshi Noda et al.|PLoS ONE|2024Cited by 16